|
π¬
|
Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo.
A. L. Bon,
G. Schiavoni,
G. D'agostino,
I. Gresser,
F. Belardelli,
D. Tough
|
9 |
2001 |
9
π¬
|
|
π¬
|
Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer
L. Bracci,
G. Schiavoni,
A. Sistigu,
F. Belardelli
|
9 |
2013 |
9
π¬
|
|
π
|
Type I interferons produced by dendritic cells promote their phenotypic and functional activation.
7 auth.
M. Montoya,
G. Schiavoni,
F. Mattei,
I. Gresser,
F. Belardelli,
P. Borrow,
...
D. Tough
|
9 |
2002 |
9
π
|
|
π¬
|
IL-15 Is Expressed by Dendritic Cells in Response to Type I IFN, Double-Stranded RNA, or Lipopolysaccharide and Promotes Dendritic Cell Activation1
F. Mattei,
G. Schiavoni,
F. Belardelli,
D. Tough
|
8 |
2001 |
8
π¬
|
|
π¦
|
ICSBP Is Essential for the Development of Mouse Type I Interferon-producing Cells and for the Generation and Activation of CD8Ξ±+ Dendritic Cells
8 auth.
G. Schiavoni,
F. Mattei,
P. Sestili,
P. Borghi,
M. Venditti,
H. Morse,
...
F. Belardelli,
L. Gabriele
|
8 |
2002 |
8
π¦
|
|
π
|
Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1
42 auth.
Erika Vacchelli,
Yuting Ma,
E. E. Baracco,
A. Sistigu,
D. Enot,
F. Pietrocola,
H. Yang,
Sandy Adjemian,
Kariman Chaba,
M. Semeraro,
M. Signore,
A. De Ninno,
V. Lucarini,
Francesca Peschiaroli,
L. Businaro,
...
A. Gerardino,
G. Manic,
T. Ulas,
Patrick GΓΌnther,
J. Schultze,
O. Kepp,
G. Stoll,
C. Lefebvre,
C. Mulot,
F. Castoldi,
S. Rusakiewicz,
S. Ladoire,
L. Apetoh,
J. M. Bravo-San Pedro,
M. Lucattelli,
C. Delarasse,
V. Boige,
M. Ducreux,
S. Delaloge,
C. Borg,
F. AndrΓ©,
G. Schiavoni,
I. Vitale,
P. Laurent-Puig,
F. Mattei,
L. Zitvogel,
G. Kroemer
|
8 |
2015 |
8
π
|
|
π¦
|
Cyclophosphamide synergizes with type I interferons through systemic dendritic cell reactivation and induction of immunogenic tumor apoptosis.
13 auth.
G. Schiavoni,
A. Sistigu,
M. Valentini,
F. Mattei,
P. Sestili,
F. Spadaro,
M. Sanchez,
S. Lorenzi,
Maria Teresa DβUrso,
F. Belardelli,
...
L. Gabriele,
E. Proietti,
L. Bracci
|
8 |
2011 |
8
π¦
|
|
π’
|
Eosinophils: The unsung heroes in cancer?
8 auth.
G. Varricchi,
M. Galdiero,
S. Loffredo,
V. Lucarini,
G. Marone,
F. Mattei,
...
G. Marone,
G. Schiavoni
|
7 |
2018 |
7
π’
|
|
π¦
|
Cyclophosphamide induces type I interferon and augments the number of CD44(hi) T lymphocytes in mice: implications for strategies of chemoimmunotherapy of cancer.
7 auth.
G. Schiavoni,
F. Mattei,
T. Pucchio,
S. Santini,
L. Bracci,
F. Belardelli,
...
E. Proietti
|
7 |
2000 |
7
π¦
|
|
π’
|
IL-33 restricts tumor growth and inhibits pulmonary metastasis in melanoma-bearing mice through eosinophils
15 auth.
V. Lucarini,
Giovanna Ziccheddu,
I. Macchia,
V. La Sorsa,
Francesca Peschiaroli,
Carla Buccione,
A. Sistigu,
M. Sanchez,
S. Andreone,
Maria Teresa DβUrso,
...
M. Spada,
D. Macchia,
C. Afferni,
F. Mattei,
G. Schiavoni
|
7 |
2017 |
7
π’
|
|
π¦
|
The Tumor Microenvironment: A Pitch for Multiple Players
G. Schiavoni,
L. Gabriele,
F. Mattei
|
7 |
2013 |
7
π¦
|
|
π¦
|
Type I Interferons as Stimulators of DC-Mediated Cross-Priming: Impact on Anti-Tumor Response
G. Schiavoni,
F. Mattei,
L. Gabriele
|
7 |
2013 |
7
π¦
|
